Eqis Capital Management, Inc. Aflac Inc Transaction History

Eqis Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$76.2 - $85.86 $274,548 - $309,353	-3,603 Reduced 27.98%	9,275 $796,000
Q4 2023 Feb 14, 2024	SELL	$75.43 - $84.35 $179,447 - $200,668	-2,379 Reduced 15.59%	12,878 $1.06 Million
Q3 2023 Nov 13, 2023	BUY	$69.57 - $77.95 $216,014 - $242,034	3,105 Added 25.55%	15,257 $1.17 Million
Q2 2023 Aug 14, 2023	BUY	$63.91 - $70.36 $776,634 - $855,014	12,152 New	12,152 $848,000
Q1 2018 Apr 06, 2018	SELL	$41.62 - $45.85 $754,570 - $831,260	-18,130 Closed	0 $0
Q4 2017 Jan 25, 2018	BUY	$40.99 - $44.63 $52,016 - $56,635	1,269 Added 7.53%	18,130 $1.59 Million
Q3 2017 Oct 03, 2017	BUY	$39.85 - $42.13 $671,910 - $710,353	16,861	16,861 $1.37 Million

1,694

371M

4.13M

2.31M

Ticker AFL
Exchange NYSE
Sector Financial Services
Industry Insurance—Life
Shares Outstandng 631,916,032
Market Cap $63.8B
Description
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving ...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.